Shareholder alert: kaskela law llc announces investigation of nrx pharmaceuticals, inc. and encourages long-term nrxp / brpa shareholders to contact the firm

Philadelphia , june 15, 2023 /prnewswire/ -- kaskela law llc announces that it is investigating nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx") on behalf of the company's long-term shareholders. nrx is a clinical-stage pharmaceutical company.
NRXP Ratings Summary
NRXP Quant Ranking